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Abundance of type XVI collagen mRNA in normal
human dermal fibroblasts explanted from different
horizontal layers was determined using RNase protec-
tion assays. Type XVI collagen mRNA level in the
fibroblasts explanted from the upper dermis was
greater than those of the middle and lower dermis.
The antibody raised against the synthetic N-terminal
noncollagenous region reacted with »210 kDa colla-
genous polypeptide in the culture medium of
fibroblasts. Immunohistochemical study of normal
human skin demonstrated that the antibody reacted
preferentially with the fibroblasts and the extracellular
matrix in the upper dermis rather than those in the
middle and lower dermis. Type XVI collagen mRNA
Collagen, the major constitutes of connective tissue,is a large family of proteins with distincttissue distribution and functions (Vuorio andCrombrugghe, 1990; Chu and Prockop, 1993).To date, 19 different types of collagen have been
described in vertebrates. On the basis of the structure and function
of the proteins, the collagen are generally divided into two
categories: the fibril-forming collagens and the non-fibril-forming
collagens. The fibril-forming collagens, types I–III and V and XI,
have long central triple helical domains with Gly–X–Y repeating
sequences and form highly organized fibrils in a quarter-staggered
fashion. The latter class of collagens are very heterogeneous in size
and have imperfections in the Gly–X–Y repeating sequence as a
common feature. In the latter class, types IX, XII, and XIV
collagens form a subgroup named the fibril-associated collagens
with interrupted triple helices (FACIT) (Shaw and Olsen, 1991).
The gene of type XVI collagen has recently been isolated from
human fibroblast and placenta cDNA libraries. The predicted
polypeptide designated as α1(XVI) consists of 10 collagenous
domains which were interspersed with 11 noncollagenous domains
exhibiting several structural features characteristically seen in mem-
bers of FACIT or bullous pemphigoid antigen 180 (type XVII
collagen) (Li et al, 1991; Pan et al, 1992; Yamaguchi et al, 1992).
It has been shown that the FACIT members are localized on the
surface of major collagen fibrils and may serve as molecular bridges
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level was elevated 2.3-fold in localized scleroderma
and 3.6-fold in systemic scleroderma compared with
keloid and normal controls. Immunofluorescent study
revealed that an intense immunoreactivity with the
antibody was observed in the upper to lower dermal
matrix and fibroblasts in the skin of systemic
scleroderma as compared with normal skin. The
results suggest that expression of type XVI collagen, a
member of fibril-associated collagens with interrupted
triple helices, in human skin fibroblasts can be
heterogeneous in the dermal layers and can be
modulated by some fibrotic diseases. Key words:
dermal fibroblast/scleroderma/type XVI collagen. J Invest
Dermatol 113:246–250, 1999
that are responsible for maintaining the structural integrity of the
extracellular matrix. Although the structural similarities between
FACIT and type XVI collagen may suggest a similar function, no
information on its regulation and physiologic function is available.
In skin, it has been demonstrated that specific type XVI collagen
transcripts are detected in cultured dermal fibroblasts and
keratinocytes (Pan et al, 1992). Here, we studied the localization
of type XVI collagen in human skin, and the expression in the
cultured dermal fibroblasts explanted from different dermal layers
and derived from several fibrotic diseases.
MATERIALS AND METHODS
Fibroblast culture Normal human skin specimen was obtained from
surgical operation of benign skin tumors. Skin fibroblast culture was
established by a routine explant method. The fibroblasts outgrown from
the skin were subcultured after trypsin treatment (0.25%) at a split ratio of
1:1 and designated passage 1. The fibroblasts were grown in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal bovine serum,
62.5 µg penicillin per ml and 0.01% streptomycin in a humidified
atmosphere of 5% CO2/95% air. Third passage fibroblasts were used in
this study.
In an experiment, skin specimens were divided using a scalpel under a
microscope into three horizontal layers, i.e., the upper, middle, and lower
dermis. The dermal layers were cut into fragments and explanted on
35 mm diameter culture dishes (Izumi et al, 1995a). Third passage fibroblasts
were used.
Patients Skin biopsies were obtained from five patients with systemic
scleroderma, three with localized scleroderma, three with keloid and three
age-, sex-, and site-matched normal individuals as summarized in Table I.
Patients with systemic scleroderma were all at the sclerotic stages and had
lung and esophagus involvement. Patients with localized scleroderma,
including one with morphea, one with generalized morphea, and one with
linear scleroderma, had sclerotic skin lesions. The patients with keloid
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Table I. Summary of the patients
Age/sex Site Stage
Normal 1 41/f fore arm
2 36/f breast
3 38/f forearm
Localized 1 35/f breast sclerotic
Scleroderma 2 20/f forearm sclerotic
3 33/m breast sclerotic
Systemic 1 48/f forearm sclerotic
Scleroderma 2 26/f forearm sclerotic
3 36/f forearm sclerotic
4 32/f forearm sclerotic
5 42/f forearm sclerotic
Keloid 1 18/f breast
2 25/f breast
3 18/f breast
were all diagnosed by histologic studies. Full-thickness skin specimens were
cut into small pieces, explanted and cultured in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal bovine serum as described above.
Northern blot and ribonuclease protection assays Total RNA was
isolated from the cultured cells with guanidine thiocyanate (Chomczynski
and Sacchi, 1987) and adjusted to a concentration of 2 µg per µl and
stored at –80°C. Ten micrograms of RNA was denatured in deionized
1 M glyoxal/10 mM phosphate buffer, pH 6.5 at 50°C for 1 h and resolved
on 1% agarose gel electrophoresis and blotted on to nylon membranes
(Pall Biosupport, Port Washington, NY). The blots were prehybridized in
the solution (50% deionized formamide, 5 3 Denhardt’s solution, 0.1%
sodium dodecyl sulfate (SDS), 100 µg tRNA per ml, 5 3 sodium citrate/
chloride buffer) at 42°C for 24 h, then hybridized with 32P-labeled probes
(µ10 cpm DNA per µg). Human proα1(I) (Hf-677) (Bernard et al, 1983a),
proα2(I) (Hf-32) (Bernard et al, 1983b), α1(XVI) (Pan et al, 1992; Yamaguchi
et al, 1992) and glyceraldehyde-3-phosphate-dehydrogenase (Fort et al,
1985) cDNA were labeled with [α-32P]dCTP (110 TBq per mmol)
(Amersham, Bucks, U.K.) by multiprime DNA labeling system (Amersham).
The filters were washed with 2 3 sodium citrate/chloride buffer/0.1%
SDS at room temperature for 2 3 30 min and 0.1 3 sodium citrate/
chloride buffer/0.1% SDS at room temperature for 2 3 30 min, then
exposed to X-ray film (Fuji RX, Rochester, NY).
Ribonuclease protection assays were used to determine quantitatively
the changes in steady-state level of type XVI collagen mRNA in dermal
fibroblasts. The fragment (BamHI/PstI, 604 bp) containing the N-terminal
region of α1(XVI) collagen (Pan et al, 1992) was subcloned into pGEM
vector (Promega, Madison, WI). Anti-sense RNA probes were transcribed
from the template sequences with T7 RNA polymerase and labeled with
[α-32P]UTP (16 TBq per mmol, Amersham) according to the supplier’s
protocol (Promega). Full-length transcripts (604 bp) were purified from
acrylamide (6% acrylamide/8 M urea) gel and used as probes (specific
activity, 2.2 3 108 RNA per µg). The probes were hybridized with
sample RNAs at 42°C overnight in the solution containing 80% deionized
formamide, 40 mM 1,4 piperazinediethanesulfonic acid, pH 6.4, 400 mM
sodium acetate, pH 6.4, and 1 mM ethylenediamine tetraacetic acid
(EDTA), then digested with RNase A (10 units per ml) and RNase T1
(2000 units per ml) (Ambion, Austin, TX) at 37°C for 3 h. The protected
RNA fragments were analyzed on sequence gel (6% acrylamide/8 M urea)
and exposed on X-ray films at –80°C for 24–48 h (Azuma et al, 1994).
The fluorograms were scanned with a densitometer (Cliniscan, Helena
Laboratories, Beaumont, TX).
Production of antibody for type XVI collagen peptide and immuno-
staining of human skin Based on the hydrophilicity characteristics
(Hopp and Woods, 1981), a sequence of 18 amino acid residues,
TQPTRRVFPRGLPEEFAL, in the N-terminal noncollagenous domain
of α1(XVI) was selected for antibody production. The peptide synthesized
by solid-phase procedure with automated peptide synthesizer (model 990;
Beckman Instrument) was purchased from the Peptide Institute (Minoh,
Osaka). The peptide was purified by reverse phase high-performance
liquid chromatography (Beckman Instrument, Fullerton, CA) with a C-
18 (250 3 4.6 mm) semipreparative column. The synthetic peptide was
coupled to hemocyanin in 20 mM sodium phosphate buffer, pH 7.5 for
3 h. The peptide–hemocyanin complex was mixed with complete Freund’s
adjuvant (Life Technologies, Grand Island, NY) and injected intraperitone-
ally into rabbits. Antibodies were purified from the anti-serum by protein
Figure 1. Concentration-dependent correlation between input
RNA and a1 (XVI) mRNA in RNase protection assay. (a) Various
amounts of RNA (0–40 µg) isolated from cultured fibroblasts were
hybridized with fixed amount of 32P-labeled anti-sense RNA probes at
42°C overnight. RNA-RNA complex was digested with RNases at 37°C
for 3 h. RNase-protected fragment (604 bp) (arrowhead) was resolved on
polyacrylamide gel and autoradiographed at –80°C for 1–2 d. First lane
indicated control assay performed without RNase digestion. Standard
molecular markers were shown in arrows. (b) Autoradiograms were scanned
with a densitometer. The values obtained from duplicate assays were shown
by open circles.
A-TSK gel (Amersham). The peptide–agarose affinity gel was prepared by
coupling the peptide to Affi-Gel 15 (Bio-Rad Laboratories, Richmond, CA)
according to the manufacturer’s protocol. The peptide-specific antibody was
eluted from the column with 0.1 M citrate buffer, pH 3.0. The anti-α1
(XVI) collagen antibody column was prepared by coupling the eluted
antibody to Affi-Gel 15 as described above.
Normal or systemic scleroderma skins were embedded in OCT and
snap-frozen. The specimens were cut into 5 µm sections and fixed with
acetone. The sections were incubated with affinity-purified anti-α1(XVI)
collagen peptide antibody for 24 h at 1:300 dilution. Bound antibody was
visualized with biotin-conjugated or fluorescein isothiocyanate-conjugated
anti-rabbit immunoglobulins (1:20) (Dako, Glostrup, Denmark). Some
sections were counterstained with hematoxylin.
Western blot Conditioned media (200 ml) harvested from the upper
dermal fibroblasts were mixed with protease inhibitor cocktails containing
1 mM EDTA, N-ethylmaleimide (NEM), and phenylmethylsulfonyl fluor-
ide. Proteins were precipitated with 176 mg per ml ammonium sulfate
and separated on 2%–15% gradient SDS–polyacrylamide gel electrophoresis
(PAGE) under reducing conditions, transferred to nitrocellulose membranes
(Schleicher & Schnell, Keene, NH) in a tank blotter in 25 mM Tris/
0.192 M glycine, pH 8.3/20% methanol at 30 V overnight (Towbin et al,
1979). The filters were blocked with 5% bovine serum albumin in 10 mM
Tris–HCl, pH 8.0/150 mM NaCl/0.05% Tween for 2 h and incubated
with purified anti-α1(XVI) collagen antibody at 1/1000 dilution for 24 h.
The blots were then washed with Tris–HCl, pH 8.0/150 mM NaCl/
0.05% Tween for 3 3 10 min and incubated with second antibody (anti-
rabbit immunoglobulins) (Dako) at 1/1000 dilution for 1 h. Antigens were
visualized using chemiluminescence (ECL, Amersham).
Biosynthesis of a1(XVI) collagen Fibroblasts explanted from the upper
dermis were labeled with 35Smethionine (40 TBq per mmol; Amersham)
for 24 h in serum-free Dulbecco’s modified Eagle’s medium supplemented
with 30 µg per ml ascorbic acid. Culture medium was harvested and mixed
with protease inhibitor cocktails (1 mM EDTA, NEM and phenylmethylsul-
fonyl fluoride), then stored at –80°C until use. Cells were homogenized
in 50 mM Tris–HCl, pH 7.4, 1 mM EDTA, 1 mM NEM, 1 mM
phenylmethylsulfonyl fluoride and 0.3% NP-40 at 4°C, then centrifuged
at 10,000 3 g for 30 min at 4°C. The supernatant of cell pellet and culture
medium were mixed and applied directly to the anti-α1(XVI) collagen
antibody column. Bound proteins were eluted with 0.1 M citrate buffer
at pH 6.0, pH 5.0, pH 4.0, and pH 3.0, then subjected to SDS–
PAGE after lyophilization. The elution of the proteins was monitored by
spectrometer (Beckman LS 9800).
Statistical studies To assess the statistical significance of differences
observed in the levels of α1(XVI) collagen mRNA of normal, localized
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Figure 2. Type XVI collagen expression in the fibroblasts derived
from the upper, middle, and lower dermis. (a) RNA was isolated
from cultured fibroblasts derived from the upper (lane 1), middle (lane 2),
and lower dermis (lane 3). Abundance of mRNA was determined by
RNase protection assay in α1 (XVI) collagen and by northern blot assay
in α1(I) and α2(I) collagen chains. (b) Autoradiograms were scanned with
a densitometer. Values are normalized to the amount of glyceraldehyde-3-
phosphate-dehydrogenase mRNA. The values obtained from duplicate
assays were shown.
scleroderma, systemic scleroderma, and keloid. A one-sided Student’s t test
was performed. p , 0.05 was considered to be significant.
RESULTS
a1(XVI) mRNA level in the upper dermal fibroblasts is
higher than the middle and lower dermal fibroblasts For
quantitative analysis of α1(XVI) mRNA we employed RNase
protection assays, as we were not able to obtain enough signals in
skin fibroblasts by northern blot assays. To optimize the amounts
of probe and input sample RNA, pilot assays were carried out with
a range of total cellular RNA (0–40 µg) using a constant amount
of anti-sense probe (50 pg of α1(XVI) anti-sense probe calculated
from specific activity of 2.0 3 108 cpm per µg). The results
demonstrated that sample RNA with a range of 10–40 µg was well
correlated with the amount of α1(XVI) anti-sense probe (Fig 1).
On the base of this result, 20 µg sample RNA was used for the
subsequent assays.
The level of α1(XVI) mRNA was highest in the upper dermal
fibroblasts and lowest in the lower dermal fibroblasts. No significant
differences in α1(I), α2(I), and glyceraldehyde-3-phosphate-dehy-
drogenase mRNA levels were observed throughout the dermis
(Fig 2a), which was in agreement with the previous studies (Tajima
and Pinnell, 1981; Izumi et al, 1995a). Quantitative determination
demonstrated that the amount of α1(XVI) mRNA in the upper
dermal fibroblasts was four times more than that of the lower
Figure 3. Specificity of the antibody raised against amino terminal
noncollagenous domain of a1 (XVI). (a) Conditioning media of the
upper dermal fibroblasts were recovered from cultured fibroblasts and
mixed with protease inhibitor cocktails (1 mM EDTA, NEM, and
phenylmethylsulfonyl fluoride). The proteins were precipitated with 176 mg
per ml ammonium sulfate and resolved on 2%–15% SDS–PAGE under
reducing conditions, then blotted on to nitrocellulose filters. The filters
were stained with the affinity-purified antibody for synthetic α1 (XVI)
collagen peptide (lane 1). An aliquot of the precipitate was digested by
purified bacterial collagenase at 37°C for 2 h (lane 2) in the presence of 2 mM
NEM. Antigen–antibody complex was visualized by chemiluminescence. (b)
[35S]Labeled proteins of culture media and cells were applied to the
antibody column and eluted with 0.1 M citrate buffer, at pH 6.0, pH 5.0,
pH 4.0, and pH 3.0. The fractions of pH 3.0 were collected and the
proteins were precipitated with 176 mg per ml ammonium sulfate. The
precipitates were digested without (lane 2) or with bacterial collagenase in
the presence of 2 mM NEM at 37°C for 2 h (lane 3). The digests were
resolved on 2%–15% SDS–PAGE under reducing conditions followed by
autoradiography. Total proteins prior to the application to the antibody
column was indicated in lane 1. Molecular markers were shown in the
space between (a) and (b).
dermal fibroblasts (Fig 2b). We used the fibroblasts explanted from
the upper dermis in the further experiments (see below).
Type a1(XVI) collagen localizes preferentially in the papillary
dermis To assess the specificity of the antibody raised against
α1(XVI) collagen peptide, we performed western blot assay and
immunoaffinity column chromatography. Western blot assay of the
proteins in the cultured conditioning media recovered from normal
upper dermal fibroblasts demonstrated the major polypeptide with
a molecular weight of 210 kDa and minor 65 kDa polypeptide
(arrowheads in Fig 3a). Both polypeptides were found to be sensitive
to purified bacterial collagenase (Fig 3a). The latter polypeptide
was considered to be a degradation product of the former. The
antibody did not reacted with collagen types I, III, IV, and VI
purified from human placenta (not shown). [35S]Labeled proteins
of cultured human skin fibroblasts were applied to type XVI
collagen antibody column and eluted with 0.1 M citrate buffer, at
pH 6.0, pH 5.0, pH 4.0, and pH 3.0. SDS–PAGE and autoradiogram
of the pH 3.0 fraction showed two polypeptides with the molecular
weights of µ210 kDa and 40 kDa as a minor component (arrow-
heads in Fig 3b) which were both digested with bacterial colla-
genase. These low molecular weight polypeptides (65 and 40 kDa)
were considered to be degraded products of 210 kDa protein, as
α1(XVI) chain was found to undergo proteolytic processing to
several lower molecular polypeptides (Tillet et al, 1995). We
therefore did not study these low molecular polypeptides further.
The antibody showed a strong reaction with the fibroblasts in
the papillary dermis (arrows in Fig 4a) but not with the fibroblasts
in the middle and lower dermis (Fig 4b). The fibroblasts in the
papillary dermis were mostly stained with the antibody (Fig 4a)
but some fibroblasts did not (arrowheads in Fig 4a). The antibody
reacted with the extracellular matrix in the papillary dermis (Fig 4a)
but weakly in the middle and lower dermis (Fig 4b).
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Figure 4. Immunostaining of normal human skin with affinity-
purified antibody for synthetic type XVI collagen peptide. Frozen
sections of normal human skin were stained with affinity-purified anti-α1
(XVI) collagen antibody. Bound antibody was visualized with a biotin-
labeled second antibody. The fibroblasts and extracellular matrix in the
papillary dermis were stained positively (a) and those in the reticular dermis
were stained weakly (b). Note some negatively stained fibroblasts (arrowheads
in a) and positively stained fibroblasts (arrows in a) in the papillary dermis.
Hematoxylin stain, scale bar: 10 µm.
a1(XVI) mRNA level in the fibroblasts of the patients with
localized and systemic scleroderma and keloid The levels
of α1(XVI) mRNA were slightly elevated in localized scleroderma
and markedly elevated in systemic scleroderma (Fig 5a).
Quantitative analysis revealed 2.3-fold increase in α1(XVI)
mRNA in localized scleroderma (p , 0.05) and approximately
3.6-fold increase in systemic scleroderma fibroblasts (p , 0.05). In
the patients with keloid, there was no significant change in α1(XVI)
mRNA level compared with that of normal controls (Fig 5b).
We further determined α1(XVI) mRNA levels of an additional
six normal control cell lines of those aged 22–51 (two males and
four females), because the ages of three normal control cell lines
were varied and not well matched to those of the patients. The
results revealed no significant changes in α1(XVI) mRNA levels
in six normal controls (data not shown).
Immunofluorescent studies of systemic scleroderma
skins Skin specimens of systemic scleroderma (case 1 in Table I)
and the normal individual were stained with anti-α1 (XVI) collagen
antibody. The antibody reacted with the fibroblasts and extracellular
matrix throughout the dermis in the skins of systemic scleroderma,
whereas the antibody showed an intense reaction with the superficial
dermis, but weak or no reaction with the mid and deep dermis in
the normal skin (Fig 6). Other cases of systemic scleroderma (cases
Figure 5. Type XVI collagen expression in the patients with
localized scleroderma, systemic scleroderma, and keloid. (a) Total
RNA was isolated from the cells and hybridized with glyceraldehyde-3-
phosphate-dehydrogenase cDNA (upper panel) or α1(XVI) anti-sense RNA
(lower panel) probes. Lanes 1 and 2 in the lower panel indicate positive and
negative control experiments performed without RNase and without
sample RNA, respectively. (b) Autoradiograms were scanned with a
densitometer. Values are mean 6 SD from duplicate assays (b). N, normal
(n 5 3); L, localized scleroderma (n 5 3); S, systemic scleroderma (n 5
5); K, keloid (n 5 3). * and **, statistical significance at p , 0.05.
Figure 6. Immunofluorescent staining of the skins of systemic
scleroderma patients. Cryostat sections of skin specimens taken from
normal (a) or systemic scleroderma (case 1) (b) were incubated with anti-
α1(XVI) collagen antibody. Antigens were visualized with fluorescein
isothiocyanate-labeled second antibody. An intense immunoreactivity in
the fibroblasts and dermal matrix in systemic scleroderma skin compared
with normal skin is noted. Scale bar: 50 µm.
2 and 5) showed essentially similar staining patterns to that of case
1 (not shown).
DISCUSSION
Skin fibroblast cultures systems have been frequently utilized for
the analysis of collagen regulation in normal state or hereditary
skin diseases. Because it has been demonstrated that human skin
fibroblasts in culture contain heterogeneous populations in the
mitotic activity (Harper and Grove, 1979), responses to exogenous
factors (Kaufman et al, 1975; Tajima and Izumi, 1996) and synthesis
of extracellular matrices (Izumi et al, 1995a; Tajima and Izumi,
1996), we attempted to study the expression of type XVI collagen
in different dermal layers. The results demonstrated that type XVI
collagen expression is greater in the upper dermal fibroblasts than
middle/lower dermal fibroblasts. This basic information of the
modulation of type XVI collagen expression in human skin
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fibroblasts may be important for the studies on abnormal metabolism
of type XVI collagen in cultured fibroblasts.
These immunohistochemical studies have demonstrated that the
distribution of type XVI collagen in the dermis is heterogeneous;
the antibody preferentially stained the upper dermal matrix and
fibroblasts rather than the lower dermal matrix and fibroblasts. The
results tempted us to study the expression of α1(XVI) collagen in
the fibroblasts explanted from the upper, middle, and lower dermis.
The predominant staining in the superficial dermis may be related
with the higher potential of type XVI collagen expression in the
cultured fibroblasts explanted from the superficial dermis. A punct-
ate staining of type XVI collagen in the rat superficial dermis has
been previously reported by others (Tillet et al, 1995). The staining
may reflect the positively stained fibroblasts in the upper dermis,
although they did not comment on this point. The antibody stained
most, but not all of the upper dermal fibroblasts. Type XVI
collagen-positive fibroblasts may represent a specific phenotype of
heterogeneous populations of fibroblasts. Indeed, the antibody was
found to stain the matrix and cells of dermatofibroma but not those
of dermatofibrosarcoma protuberans (manuscript in preparation).
Systemic and localized scleroderma are characterized by systemic
and localized accumulation of collagen in the skin. The accumula-
tion of collagen is believed to be responsible for the overproduction
of collagen by skin fibroblasts. The overproduction of type I, III,
and VI collagens, major interstitial collagens in the dermal connect-
ive tissue, by systemic and localized scleroderma fibroblasts has
been demonstrated (Graves et al, 1983; Krieg et al, 1985; Peltonen
et al, 1990). Our study demonstrated that the overproduction and
accumulation of type XVI collagen, a FACIT collagen, is also
involved in the pathogenesis of fibrotic change in systemic and
localized scleroderma. It is noted that keloid fibroblasts, in contrast to
systemic and localized scleroderma fibroblasts, did exhibit unaltered
expression of α1(XVI) collagen. Because the increase in type I
collagen expression rather than type III collagen in keloid fibroblasts
has been demonstrated (Uitto et al, 1985), type XVI collagen as
well as type III collagen may not be actively involved in the fibrosis
of keloid.
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